CD19 and myeloid leukemia: Following the expansion, CAR T cells (n = 7) were co-cultured at different E:T ratios with CFSE-labeled CD19-positive Raji lymphoma cells and CD19-negative THP1 myeloid leukemia cells for 4 h.